The 10 Best Performing Canadian Medical Marijuana Stocks of 2016
Canada’s medical marijuana space, due to the country’s first mover advantage over many other nations, has attracted international attention. The sector has not disappointed, delivering solid, sometimes spectacular, returns to investors at home and abroad.
Under Canada’s new MMPR (Marihuana for Medical Purposes Regulations) there have been just 34 licenses awarded to grow and/or sell marijuana and 22 licenses to sell cannabis oil. Many of these companies have chosen the public route to raise capital, and their continued growth looks probably, if not nearly certain. Pacific International (PI) Securities analyst Jason Zandberg thinks the next few years will be ones of strong growth for the Canadian marijuana market, with demand originating from both recreational and medicinal users. The analyst thinks that in 2019, which he estimates to be the first user after recreational use is permitted, the medical marijuana market will be worth $4.6-billion. Zandberg expects this will grow 10...
This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.
Follow us on Instagram
Connect with us on Linkedin